Abstract:Enterotoxigenic Escherichia coli (ETEC) causes severe diarrhea in piglets. The current primary approach for ETEC prevention and control relies on antibiotics, as few effective vaccines are available. Consequently, an urgent clinical demand exists for developing an effective vaccine to combat this disease. Here, we utilized food-grade Lactococcus lactis NZ3900 and expression plasmid pNZ8149 as live vectors, together with the secreted expression peptide Usp45 and the cell wall non-covalent linking motif LysM, to effectively present the mutant LTA subunit, the LTB subunit of heat-labile enterotoxin, and the FaeG of F4 pilus on the surface of recombinant lactic acid bacteria (LAB). Combining three recombinant LAB as a live vector oral vaccine, we assessed its efficacy in preventing F4+ ETEC infection. The results demonstrate that oral immunization conferred effective protection against F4+ ETEC infection in mice and piglets lacking maternal antibodies during weaning. Sow immunization during late pregnancy generated significantly elevated antibodies in colostrum, which protected piglets against F4+ ETEC infection during lactation. Moreover, booster immunization on piglets during lactation significantly enhanced their resistance to F4+ ETEC infection during the weaning stage. This study highlights the efficacy of an oral LAB vaccine in preventing F4+ ETEC infection in piglets by combining the sow immunization and booster immunization of piglets, providing a promising vaccination strategy for future prevention and control of ETEC-induced diarrhea in piglets.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop an effective vaccine to prevent piglet diarrhea caused by F4+ enterotoxigenic Escherichia coli (ETEC). Specifically, the research aims to provide effective protection against F4+ ETEC infection by constructing a recombinant lactic acid bacteria (LAB) live - vector oral vaccine. ### Research Background and Problem Description 1. **Pathogenicity of ETEC**: - ETEC is one of the main pathogens causing severe diarrhea in piglets, especially around the weaning stage, which seriously affects the health and growth of piglets. - ETEC mainly causes intestinal infections through adhesins (such as F4/K88 fimbriae) and enterotoxins (such as heat - labile enterotoxin LT and heat - stable enterotoxin ST), resulting in diarrhea and dehydration. 2. **Limitations of Existing Prevention and Control Measures**: - At present, antibiotics are mainly relied on to prevent and control ETEC infections, but this method has the risk of drug resistance, and long - term use of antibiotics is harmful to the environment and animal health. - Although some vaccines are available, their immune effects are limited and they have not been widely applicable to different regions and multiple serotypes of ETEC. 3. **Research Objectives**: - Develop a live - vector oral vaccine based on recombinant lactic acid bacteria to provide a safer and more effective prevention method. - Induce the host to produce an immune response by expressing key antigens of ETEC (such as the mutated LT A subunit, LT B subunit, and F4 fimbrial protein FaeG), thereby preventing F4+ ETEC infection. ### Solutions The researchers utilized the following strategies: - **Vector Selection**: The food - safety - grade Lactococcus lactis NZ3900 was selected as a vector, combined with the expression plasmid pNZ8149. - **Antigen Display**: The mutated LT A subunit (dmLTA), LT B subunit, and F4 fimbrial protein FaeG were displayed on the surface of recombinant lactic acid bacteria through the secretory expression peptide Usp45 and the cell - wall non - covalent - binding motif LysM. - **Vaccine Construction**: Three recombinant lactic acid strains, LAB - dmLTA, LAB - LTB, and LAB - faeG, were constructed and mixed to prepare an oral vaccine. - **Immune Experiments**: The immune protection effects of this vaccine were evaluated through immune experiments in mice and piglets, especially the effects of immunization in the late pregnancy of sows and booster immunization during the weaning period. ### Main Conclusions - Oral immunization can effectively protect mice and piglets lacking maternal antibodies from F4+ ETEC infection. - Immunization in the late pregnancy of sows can significantly increase the antibody levels in colostrum and protect piglets during the lactation period. - Booster immunization during the weaning period can significantly enhance the resistance of piglets to F4+ ETEC infection. In conclusion, this study demonstrates the potential of the recombinant lactic acid bacteria live - vector oral vaccine in preventing F4+ ETEC infection, providing a new strategy for the prevention and control of piglet diarrhea caused by ETEC in the future.

Application of Recombinant Lactic Acid Bacteria (LAB) Live Vector Oral Vaccine in the Prevention of F4+ Enterotoxigenic Escherichia coli

Development of a new candidate vaccine against piglet diarrhea caused by Escherichia coli

Oral immunization of a live attenuated Escherichia coli strain expressing a holotoxin-structured adhesin-toxoid fusion (1FaeG-FedF-LTA₂:5LTB) protected young pigs against enterotoxigenic E. coli (ETEC) infection

Engineered Recombinant Escherichia Coli Probiotic Strains Integrated with F4 and F18 Fimbriae Cluster Genes in the Chromosome and Their Assessment of Immunogenic Efficacy in Vivo.

Improved Piglet Performance and Reduced Mortality and Antimicrobial use Following Oral Vaccination with a Live Non-Pathogenic Escherichia coli F4/F18 Vaccine Against Post-Weaning Diarrhoea

Avirulent K88 (F4)+ Escherichia coli strains constructed to express modified enterotoxins protect young piglets from challenge with a virulent enterotoxigenic Escherichia coli strain that expresses the same adhesion and enterotoxins.

Genetic Fusions of Heat-Labile Toxoid (lt) and Heat-Stable Toxin B (stb) of Porcine Enterotoxigenic Escherichia Coli Elicit Protective Anti-Lt and Anti-Stb Antibodies

Protective efficacy of a recombinant enterotoxin antigen in a maternal immunization model and the inhibition of specific maternal antibodies to neonatal oral vaccination

Application of a Novel Epitope- and Structure-Based Vaccinology-Assisted Fimbria-Toxin Multiepitope Fusion Antigen of Enterotoxigenic Escherichia Coli for Development of Multivalent Vaccines Against Porcine Postweaning Diarrhea

Oral Immunization against PEDV with Recombinant Lactobacillus casei Expressing Dendritic Cell-Targeting Peptide Fusing COE Protein of PEDV in Piglets

Oral immunization of mice with plant-derived fimbrial adhesin FaeG induces systemic and mucosal K88ad enterotoxigenic Escherichia coli-specific immune responses

Progress and Challenges in Vaccine Development Against Enterotoxigenic Escherichia Coli (Etec)-Associated Porcine Post- Weaning Diarrhoea (PWD)

Expression of F18 Fimbrial Adhesion F Antigen Gene(fedF) in Escherichia coli and Its Immunoprotection in BALB/c Mice(Mus musculus)

Mapping the neutralizing epitopes of enterotoxigenic (ETEC) K88 (F4) fimbrial adhesin and major subunit FaeG.

Effect of an Escherichia coli F4/F18 bivalent oral live vaccine on gut health and performance of healthy weaned pigs

Lactobacillus rhamnosus LB1 Alleviates Enterotoxigenic Escherichia coli-Induced Adverse Effects in Piglets by Improving Host Immune Response and Anti-Oxidation Stress and Restoring Intestinal Integrity

Dietary Supplementation with Lysozyme–Cinnamaldehyde Conjugates Enhances Feed Conversion Efficiency by Improving Intestinal Health and Modulating the Gut Microbiota in Weaned Piglets Infected with Enterotoxigenic Escherichia coli

A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection

Effect of Orally Administered Enterococcus Faecium Ef1 on Intestinal Cytokines and Chemokines Production of Suckling Piglets

A bovine lactoferricin-lactoferrampin-encoding Lactobacillus reuteri CO21 regulates the intestinal mucosal immunity and enhances the protection of piglets against enterotoxigenic Escherichia coli K88 challenge

Secretory Expression of K88 (F4) Fimbrial Adhesin FaeG by Recombinant Lactococcus Lactis for Oral Vaccination and Its Protective Immune Response in Mice.